These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15206694)

  • 21. UVA-1 phototherapy for the management of atopic dermatitis: a large retrospective study conducted in a low-middle income country.
    Ordóñez Rubiano MF; Arenas CM; Chalela JG
    Int J Dermatol; 2018 Jul; 57(7):799-803. PubMed ID: 29700815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The annual cost of medical care for patients with moderate to severe atopic dermatitis in Mexico. A multicenter study].
    Guevara-Sanginés E; Pérez-Rojas D; Nevárez-Sida A; Aceves MA; Barrón-Tapia MT; Abaroa-Cantú FJ; Ancona-Castro C; García-Salazar MR; Hernández-Rodríguez JM; García-Contreras F; Estrada-Aguilar L
    Rev Alerg Mex; 2020; 67(1):9-18. PubMed ID: 32447863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study.
    van Joost T; Heule F; Korstanje M; van den Broek MJ; Stenveld HJ; van Vloten WA
    Br J Dermatol; 1994 May; 130(5):634-40. PubMed ID: 8204472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health Care Resource Utilization and Costs Among Adults with Atopic Dermatitis in the United States: A Claims-Based Analysis.
    Drucker AM; Qureshi AA; Amand C; Villeneuve S; Gadkari A; Chao J; Kuznik A; Bégo-Le-Bagousse G; Eckert L
    J Allergy Clin Immunol Pract; 2018; 6(4):1342-1348. PubMed ID: 29174063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis.
    Ellis CN; Drake LA; Prendergast MM; Abramovits W; Boguniewicz M; Daniel CR; Lebwohl M; Paller AS; Stevens SR; Whitaker-Worth DL; Tong KB
    J Am Acad Dermatol; 2003 Apr; 48(4):553-63. PubMed ID: 12664019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of moderate and severe adult chronic atopic dermatitis with narrow-band UVB and the combination of narrow-band UVB/UVA phototherapy.
    Fernández-Guarino M; Aboin-Gonzalez S; Barchino L; Velazquez D; Arsuaga C; Lázaro P
    Dermatol Ther; 2016; 29(1):19-23. PubMed ID: 26301893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating the Societal Benefits of THA After Accounting for Work Status and Productivity: A Markov Model Approach.
    Koenig L; Zhang Q; Austin MS; Demiralp B; Fehring TK; Feng C; Mather RC; Nguyen JT; Saavoss A; Springer BD; Yates AJ
    Clin Orthop Relat Res; 2016 Dec; 474(12):2645-2654. PubMed ID: 27699631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The socioeconomic impact of atopic dermatitis in the United States: a systematic review.
    Mancini AJ; Kaulback K; Chamlin SL
    Pediatr Dermatol; 2008; 25(1):1-6. PubMed ID: 18304144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Burden of Atopic Dermatitis: Summary of a Report for the National Eczema Association.
    Drucker AM; Wang AR; Li WQ; Sevetson E; Block JK; Qureshi AA
    J Invest Dermatol; 2017 Jan; 137(1):26-30. PubMed ID: 27616422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research.
    Garritsen FM; Brouwer MW; Limpens J; Spuls PI
    Br J Dermatol; 2014 Mar; 170(3):501-13. PubMed ID: 24116934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of ultraviolet radiation with peaks at 300 nm and 350 nm in the treatment of atopic dermatitis.
    Jekler J; Larkö O
    Photodermatol Photoimmunol Photomed; 1990 Aug; 7(4):169-72. PubMed ID: 2076373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment.
    Ariëns LFM; van Nimwegen KJM; Shams M; de Bruin DT; van der Schaft J; van Os-Medendorp H; De Bruin-Weller M
    Acta Derm Venereol; 2019 Jul; 99(9):762-768. PubMed ID: 31073619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis.
    Berth-Jones J; Graham-Brown RA; Marks R; Camp RD; English JS; Freeman K; Holden CA; Rogers SC; Oliwiecki S; Friedmann PS; Lewis-Jones MS; Archer CB; Adriaans B; Douglas WS; Allen BR
    Br J Dermatol; 1997 Jan; 136(1):76-81. PubMed ID: 9039299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: a comparison of two dosage regimens.
    Zonneveld IM; De Rie MA; Beljaards RC; Van Der Rhee HJ; Wuite J; Zeegelaar J; Bos JD
    Br J Dermatol; 1996 Sep; 135 Suppl 48():15-20. PubMed ID: 8881899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan.
    Feldman SR; Evans C; Russell MW
    J Dermatolog Treat; 2005 Feb; 16(1):37-42. PubMed ID: 15897166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cost effectiveness of tapered versus abrupt discontinuation of oral cyclosporin microemulsion for the treatment of psoriasis.
    Hakkaart-van Roijen L; Verboom P; Redekop WK; Touw KR; Rutten FF
    Pharmacoeconomics; 2001; 19(5 Pt 2):599-608. PubMed ID: 11465304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-care resource use and current treatment of adult atopic dermatitis patients in Japan: A retrospective claims database analysis.
    Igarashi A; Fujita H; Arima K; Inoue T; Dorey J; Fukushima A; Taguchi Y
    J Dermatol; 2019 Aug; 46(8):652-661. PubMed ID: 31245879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of severe atopic dermatitis in childhood with cyclosporin.
    Zaki I; Emerson R; Allen BR
    Br J Dermatol; 1996 Sep; 135 Suppl 48():21-4. PubMed ID: 8881900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data.
    Hjelmgren J; Svensson A; Jörgensen ET; Lindemalm-Lundstam B; Ragnarson Tennvall G
    Br J Dermatol; 2007 May; 156(5):913-21. PubMed ID: 17263826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phototherapy for atopic dermatitis.
    Rodenbeck DL; Silverberg JI; Silverberg NB
    Clin Dermatol; 2016; 34(5):607-13. PubMed ID: 27638440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.